| Pharmaceutical active ingredients: |
| Propranolol Hydrochloride |
| Available forms, composition and doses of Indoblok: |
| N / A |
| Indoblok medical category: |
| Human:Antimigraine preparationsBeta-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07AA05 - Propranolol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Inderal | Propranolol Hydrochloride | AstraZeneca; Akrimax Pharmaceuticals; Cana; Four Star; Institute of Pharmaceutical Research and Technology; Nicholas Piramal; Teva; Wyeth; Zuellig Pharma |
| Inderal LA | Propranolol Hydrochloride | AstraZeneca; Akrimax Pharmaceuticals; Pfizer; Rouses Point Pharmaceuticals; Wyeth |
| Inderal Retard | Propranolol Hydrochloride | AstraZeneca |
| Inderalici | Propranolol Hydrochloride | AstraZeneca |
| Indobloc | Propranolol Hydrochloride | Baxter; Viatris |
| InnoPran | Propranolol Hydrochloride | GlaxoSmithKline; Reliant Pharmaceuticals |
| InnoPran XL | Propranolol Hydrochloride | GlaxoSmithKline; Reliant Pharmaceuticals |
| Inpanol | Propranolol Hydrochloride | Drug Houses of Australia; U.S. Summit |
| Intermigran | Propranolol Hydrochloride | Sanol |
| Lopranol LA | Propranolol Hydrochloride | Trinity Chiesi Pharmaceuticals |